부산대학교 도서관

Amrein, Philip C. ; Attar, Eyal C. ; Fell, Geoffrey G ; Blonquist, Traci M. ; Brunner, Andrew M. ; Hobbs, Gabriela S. ; Hock, Hanno R. ; McAfee, Steven ; Narayan, Rupa ; Moran, Jenna A. ; Bergeron, Meghan ; Foster, Julia E. ; Bertoli, Christina ; McGregor, Kristin ; Burke, Meghan ; Behnan, Tanya T. ; Som, Tina T. ; Ramos, Aura Y. ; Vartanian, Megan K. ; Lombardi Story, Jennifer ; Neuberg, Donna S. ; Fathi, Amir T.

In Blood 15 November 2022 140 Supplement 1:3309-3311

Fathi, Amir T. ; Fell, Geoffrey G ; El-Jawahri, Areej ; Perl, Alexander E. ; Jonas, Brian A. ; Dias, Ajoy L. ; Mims, Alice S. ; Borate, Uma ; Ragon, Brittany Knick ; Grunwald, Michael R. ; Peters, Mary Linton B. ; Graubert, Timothy A. ; Amrein, Philip C. ; Hock, Hanno R. ; Brunner, Andrew M. ; Hobbs, Gabriela S. ; Narayan, Rupa ; Neuberg, Donna S. ; Aldoss, Ibrahim

In Blood 15 November 2022 140 Supplement 1:3284-3286

Parry, Erin Michelle ; Guieze, Romain ; Leshchiner, Ignaty ; Johnson, Connor ; Tausch, Eugen ; Parikh, Sameer A. ; Lemvigh, Camilla K ; Broséus, Julien ; Hergalant, Sébastien ; Messer, Connor ; Utro, Filippo ; Levovitz, Chaya ; Rhrissorrakrai, Kahn ; Li, Liang ; Li, Shuqiang ; Fell, Geoffrey G ; Redd, Robert A. ; Lin, Ziao ; Knisbacher, Binyamin A. ; Schneider, Christof ; Fernandes, Stacey M. ; Hess, Julian M. ; Rassenti, Laura Z. ; Kipps, Thomas J. ; Jain, Nitin ; Wierda, William G. ; Cymbalista, Florence ; Feugier, Pierre ; Kay, Neil E. ; Livak, Kenneth J ; Danysh, Brian P ; Stewart, Chip ; Neuberg, Donna S. ; Davids, Matthew S. ; Brown, Jennifer R. ; Parida, Laxmi ; Stilgenbauer, Stephan ; Getz, Gad ; Wu, Catherine J.

In Blood 15 November 2022 140 Supplement 1:1530-1533

Lloyd K; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Shern TP; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Holt LR; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Daly AE; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Anderman KJ; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Gadd MA; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Verdial FC; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Kwait RM; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Tomczyk E; Division of Plastic and Reconstructive Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Ozmen T; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Smith BL; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.; Specht MC; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. mspecht@mgh.harvard.edu.

Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Shimony, Shai ; Fell, Geoffrey G ; Chen, Evan C. ; Tsai, Harrison ; Wadleigh, Martha ; Winer, Eric S. ; Garcia, Jacqueline S. ; Luskin, Marlise R. ; Stahl, Maximilian F. ; Neuberg, Donna S. ; DeAngelo, Daniel J ; Lindsley, R. Coleman ; Stone, Richard M.

In Blood 15 November 2022 140 Supplement 1:8938-8939

Adamia, Sophia ; Chyra, Zuzana ; O'Keefe, Morgan ; Bhatt, Shruti ; Wen, Kenneth ; Fell, Geoffrey G ; Tai, Yu-Tzu ; Letai, Anthony G. ; Abiatari, Ivane ; Dorfman, David M. ; Hideshima, Teru ; Anderson, Kenneth C.

In Blood 23 November 2021 138 Supplement 1:2688-2688

Harris, Cynthia K; Kwong, J Y; Cohen, M H; Bland, Denise K; Fell, Geoffrey G; Nosé, Vania; Bossuyt, Veerle

American Journal of Clinical Pathology. Jul2022, Vol. 158 Issue 1, p142-147. 6p.

Beyerlin, Kassidy; Jimenez, Rachel; Zangardi, Mark; Fell, Geoffrey G; Edmonds, Christine; Johnson, Andrew; Bossuyt, Veerle; Specht, Michelle; Mulvey, Therese M; Moy, Beverly; Ellisen, Leif W; Isakoff, Steven J; Bardia, Aditya; Spring, Laura M

Journal of Oncology Pharmacy Practice. Dec2021, Vol. 27 Issue 8, p1883-1890. 8p.

AlJabban A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Clinical Investigation, Harvard Medical School, Boston, Massachusetts, USA.; Evans MG; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Fell GG; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Guccione JP; Los Angeles County Department of Medical Examiner-Coroner, Los Angeles, California, USA.; Edwards RA; Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, USA.; Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Padera RF; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA Askim@bwh.harvard.edu.

Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE

Zeng YC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Young OJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Harvard-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Wintersinger CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Anastassacos FM; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; MacDonald JI; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Isinelli G; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Drug and Health Sciences, University of Catania, Catania, Italy.; Dellacherie MO; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; Sobral M; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; Bai H; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Graveline AR; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Vernet A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Sanchez M; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Mulligan K; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Choi Y; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; Ferrante TC; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mooney DJ; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; Kwon IC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.; Ryu JH; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. jhryu@kist.re.kr.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. jhryu@kist.re.kr.; Shih WM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA. william_shih@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101283273 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1748-3395 (Electronic) Linking ISSN: 17483387 NLM ISO Abbreviation: Nat Nanotechnol Subsets: MEDLINE

Daniels VW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ludwig Center at Harvard, Boston, MA 02215, USA.; Zoeller JJ; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.; van Gastel N; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.; McQueeney KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Potter DS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Fell GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ferreira VG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP 13568-250, Brazil.; Instituto Nacional de Ciência e Tecnologia de Bioanalítica, INCTBio, Campinas, SP 13083-970, Brazil.; Yilma B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Gupta R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Spetz J; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA 02215, USA.; Bhola PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Endress JE; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.; Harris IS; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.; Department of Biomedical Genetics and Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, USA.; Carrilho E; Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP 13568-250, Brazil.; Instituto Nacional de Ciência e Tecnologia de Bioanalítica, INCTBio, Campinas, SP 13083-970, Brazil.; Sarosiek KA; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA 02215, USA.; Scadden DT; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.; Brugge JS; Ludwig Center at Harvard, Boston, MA 02215, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. anthony_letai@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA 02215, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101465400 Publication Model: Electronic Cited Medium: Internet ISSN: 1937-9145 (Electronic) Linking ISSN: 19450877 NLM ISO Abbreviation: Sci Signal Subsets: MEDLINE

Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Aryal A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Fell GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Fell GG; Data Science, Dana-Farber Cancer Institute, Boston, MA.; Nathan DG; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA.; Neuberg DS; Data Science, Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Chen EC; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gandler H; College of Medicine, University of Vermont, Burlington, Vermont.; Tošić I; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Fiore A; CRISPR Therapeutics, Cambridge, Massachusetts.; Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; DeAngelo DJ; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Galinsky I; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Luskin MR; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wadleigh M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Winer ES; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Leonard R; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; O'Day K; Bluebird Bio, Cambridge, Massachusetts.; de Jonge A; Karyopharm Therapeutics, Boston, Massachusetts.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Stone RM; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.; Frank DA; Division of Hematology, Winship Cancer Institute of Emory University, Atlanta, Georgia.; Garcia JS; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Sella T; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA.; Fell GG; Data Science, Dana-Farber Cancer Institute, Boston, MA.; Miller PG; Harvard Medical School, Harvard University, Boston, MA.; Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Gibson CJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA.; Rosenberg SM; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY.; Snow C; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Stover DG; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN.; Peppercorn JM; Harvard Medical School, Harvard University, Boston, MA.; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA.; Schapira L; Department of Medicine, Stanford University, Stanford, CA.; Borges VF; Division of Medical Oncology, University of Colorado Comprehensive Cancer Center, Aurora, CO.; Come SE; Harvard Medical School, Harvard University, Boston, MA.; Division of Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Warner E; Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Frank E; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Neuberg DS; Data Science, Dana-Farber Cancer Institute, Boston, MA.; Ebert BL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA.; Howard Hughes Medical Institute, Boston, MA.; Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Harvard University, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Miller PG; Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Fell GG; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA.; Foy BH; Department of Pathology & Center for Systems Biology, Massachusetts General Hospital, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA.; Scherer AK; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Gibson CJ; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Sperling AS; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Burugula BB; Department of Human Genetics, University of Michigan, Ann Arbor, MI.; Nakao T; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Uddin MM; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Warren H; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.; Bry L; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Frigault MJ; Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.; Bick AG; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Neuberg D; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA.; Higgins JM; Department of Pathology & Center for Systems Biology, Massachusetts General Hospital, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA.; Mansour MK; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Natarajan P; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.; Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Kitzman JO; Department of Human Genetics, University of Michigan, Ann Arbor, MI.; Ebert BL; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Howard Hughes Medical Institute, Bethesda, MD.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Adamia S; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. sophia_adamia@dfci.harvard.edu.; Bhatt S; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pharmacy, National University of Singapore, Singapore, 117559, Singapore.; Wen K; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Chyra Z; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Tai YT; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Pioso MS; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Abiatari I; Ilia State University, School of Medicine, Tbilisi, G409, Georgia.; Letai A; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA.; Hideshima T; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Anderson KC; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. kenneth_anderson@dfci.harvard.edu.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; PubMed not MEDLINE

Adamia S; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. sophia_adamia@dfci.harvard.edu.; Bhatt S; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pharmacy, National University of Singapore, Singapore, 117559, Singapore.; Wen K; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Chyra Z; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Fell GG; Dana-Farber Cancer Institute, Department of Data science, Boston, MA, 02215, USA.; Tai YT; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Pioso MS; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Abiatari I; Ilia State University, School of Medicine, Tbilisi, G409, Georgia.; Letai A; Dana-FArber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02215, USA.; Hideshima T; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Anderson KC; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. kenneth_anderson@dfci.harvard.edu.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Miller PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA.; Brea EJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Leick MB; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA.; Fell GG; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Jan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Gohil SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Academic Haematology, University College London Cancer Institute, London, United Kingdom; and.; Tai YT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Neuberg DS; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA.; Jacobson C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Gibson CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Howard Hughes Medical Institute, Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

How J; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Leiva O; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Bogue T; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.; Fell GG; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Bustoros MW; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA.; Connell NT; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Connors JM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Ghobrial IM; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA.; Kuter DJ; Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.; Mullally A; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School Boston, MA, 02115, USA; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Zwicker JI; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.; Fogerty AE; Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.; Hobbs GS; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Electronic address: ghobbs@partners.org.

Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE